Literature DB >> 7520221

[A case of AFP (alpha-fetoprotein) producing gastric cancer successfully treated with EAP (etoposide, adriamycin, cisplatin) therapy].

T Gonda1, H Ishida, T Higuchi, H Hirukawa, H Nakajima, I Hojo, Y Mishima.   

Abstract

A case of AFP producing gastric cancer successfully treated with EAP therapy is reported with a review of the literature. A 56-year-old male was admitted complaining of epigastralgia and back pain. He was diagnosed as having a gastric cancer with multiple liver metastases by endoscopy and computed tomography. Serum AFP level was 2,791,000 ng/ml and biopsy specimen showed AFP-positive tumor cells by PAP (peroxidase-antiperoxidase) method in hepatoid structure. Preoperative combination chemotherapy with etoposide, adriamycin and cisplatin resulted in a remarkable decrease in serum AFP level. Subtotal gastrectomy (R3) with hepatic artery cannulation was performed. The therapeutic effect by histological examination showed Grade 3 in the primary site and Grade 2 in both resional lymph nodes and liver metastasis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7520221

Source DB:  PubMed          Journal:  Gan To Kagaku Ryoho        ISSN: 0385-0684


  3 in total

Review 1.  Resection of liver metastasis from alpha-fetoprotein-producing early gastric cancer: report of a case.

Authors:  T Tsurumachi; H Yamamoto; K Watanabe; I Honda; S Watanabe; S Yamada; K Jingu; D Satomi; M Fujita
Journal:  Surg Today       Date:  1997       Impact factor: 2.549

2.  Expression of AFP and STAT3 is involved in arsenic trioxide-induced apoptosis and inhibition of proliferation in AFP-producing gastric cancer cells.

Authors:  Yanfei Jia; Dezhi Liu; Dongjie Xiao; Xiaoli Ma; Shuyi Han; Yan Zheng; Shanhui Sun; Maoxiu Zhang; Hongmei Gao; Xia Cui; Yunshan Wang
Journal:  PLoS One       Date:  2013-01-30       Impact factor: 3.240

3.  Successful paclitaxel-based chemotherapy for an alpha-fetoprotein-producing gastric cancer patient with multiple liver metastases.

Authors:  Hiromitsu Takeyama; Hirozumi Sawai; Takehiro Wakasugi; Hiroki Takahashi; Yoichi Matsuo; Nobuo Ochi; Akira Yasuda; Mikinori Sato; Yuji Okada; Hitoshi Funahashi; Yoshimi Akamo; Tadao Manabe
Journal:  World J Surg Oncol       Date:  2007-07-16       Impact factor: 2.754

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.